Atrys Health Sl Stock EBITDA
| ATRY Stock | EUR 3.20 0.08 2.44% |
Atrys Health SL fundamentals help investors to digest information that contributes to Atrys Health's financial success or failures. It also enables traders to predict the movement of Atrys Stock. The fundamental analysis module provides a way to measure Atrys Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atrys Health stock.
Atrys |
Atrys Health SL Company EBITDA Analysis
Atrys Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Atrys Health EBITDA | 6.88 M |
Most of Atrys Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atrys Health SL is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Atrys Health SL reported earnings before interest,tax, depreciation and amortization of 6.88 M. This is 99.22% lower than that of the Healthcare sector and 93.13% lower than that of the Biotechnology industry. The ebitda for all Spain stocks is 99.82% higher than that of the company.
Atrys EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atrys Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atrys Health could also be used in its relative valuation, which is a method of valuing Atrys Health by comparing valuation metrics of similar companies.Atrys Health is currently under evaluation in ebitda category among its peers.
Atrys Fundamentals
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 647.57 M | |||
| Shares Outstanding | 75.89 M | |||
| Shares Owned By Insiders | 78.47 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 2.47 X | |||
| Revenue | 121.01 M | |||
| Gross Profit | 27.78 M | |||
| EBITDA | 6.88 M | |||
| Net Income | (23.25 M) | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 146.81 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 4.67 X | |||
| Cash Flow From Operations | 4.69 M | |||
| Earnings Per Share | (0.46) X | |||
| Target Price | 10.46 | |||
| Number Of Employees | 2.4 K | |||
| Beta | 0.37 | |||
| Market Capitalization | 461.42 M | |||
| Total Asset | 565.63 M | |||
| Z Score | 1.8 | |||
| Net Asset | 565.63 M |
About Atrys Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atrys Health SL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atrys Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atrys Health SL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.